<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01747837</url>
  </required_header>
  <id_info>
    <org_study_id>12-02-213</org_study_id>
    <nct_id>NCT01747837</nct_id>
  </id_info>
  <brief_title>REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients</brief_title>
  <acronym>RESCUE</acronym>
  <official_title>REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vivek Reddy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this trial is to determine the efficacy and safety of adjunctive
      catheter-based renal sympathetic denervation (RSDN) in the primary prevention of implantable
      cardioverter defibrillator (ICD) therapy in patients with ischemic or non-ischemic
      ventricular dysfunction, who are to receive an ICD for either i) secondary prevention, or ii)
      primary prevention + inducible ventricular tachycardia (VT) by programmed ventricular
      stimulation at the time of ICD implantation. These patients will be randomized to ICD alone
      or ICD + RSDN.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale for this Study

      Despite significant advances in the management of ventricular arrhythmias through the use of
      ICD therapy, anti-arrhythmic drugs (AADs), and catheter-based ablation strategies,
      considerable challenges remain. The optimal method for the prevention of ICD shocks remains
      unclear. RSDN may be an effective tool for preventing ventricular arrhythmias, and associated
      ICD therapies, by reducing central sympathetic tone, catecholamine levels, and the
      renin-angiotensin-aldosterone system. Although RSDN has been shown to reduce the recurrence
      of VT in a case report of 2 patients suffering from electrical storm, to date no large
      prospective randomized study has evaluated the impact of RSDN in the primary prevention of
      ICD therapy in patients with ischemic or non-ischemic ventricular dysfunction. Also of note,
      there is data suggesting that RSDN may even decrease the rate of supraventricular arrhythmias
      such as atrial fibrillation. Thus, RESCUE will specifically evaluate the safety and efficacy
      of RSDN in the prevention of ICD therapy in patients with ventricular dysfunction who are to
      receive an ICD for either secondary prevention, or primary prevention if they have inducible
      VT by programmed ventricular stimulation at the time of ICD implantation.

      Description of Procedures

      Screening:

      To take part in this study, you must meet all study requirements. The screening visit tests
      and procedures are done to see if you are eligible to be in the study. The study doctor will
      review these with you and let you know if you qualify. The study doctor will make a final
      decision about your possible study qualification.

      Pre-randomization Procedures:

      After providing written consent the following data will be collected and examinations and
      tests performed:

        -  A physical examination

        -  Your blood pressure will be taken

        -  A review of your medical history and what medications you are taking

        -  A blood sample will be drawn for routine laboratory tests.

        -  Women who can have children will take a urine pregnancy test. The test must be negative
           for you to be in this study.

        -  A Transthoracic Echocardiogram (TTE)-a non-invasive test where a probe is placed on the
           chest wall and images are taken through the chest wall of the heart valves and heart
           muscle, that will measure the left ventricular size (heart wall thickness) and mitral
           inflow (flow of blood through the heart valve).

        -  An ICD interrogation (if you already have an ICD implanted) - a non-invasive test where
           a device is placed over the chest wall near your ICD, and data is transmitted wirelessly
           from your ICD to a laptop for your physician to review.

        -  An electrocardiogram (EKG) - a non-invasive test where several probes are placed on the
           chest wall that will measure electrical activity in your heart.

      Randomization:

      Immediately following the catheter ablation, patients will undergo a renal angiogram in order
      to assess suitability for catheter-based renal sympathetic denervation. A renal angiogram is
      an x-ray study of the blood vessels in the kidney to evaluate for blockage, and abnormalities
      that could be affecting the blood supply to the kidney. It is performed by injecting contrast
      dye through a catheter (a tiny tube) into the blood vessels of the kidney. The study doctor
      will assess whether the renal arteries are suitable to receive catheter-based renal
      denervation. Once you agree to participate in this study, by signing this informed consent,
      and are it is determined that you are eligible to participate you will be randomized to one
      of two treatment groups immediately following the renal angiogram.

      Randomization means that you are put into a group by chance. It is like flipping a coin. You
      will have an equal chance (50%) of being placed in either group. This study design is
      single-blinded; you will not know ahead of time which group you will be in. Only your
      physician will know which group you are randomized to.

      If you do not already have an ICD, you will undergo ICD placement as part of routine clinical
      care. You may undergo ICD placement up to 1 month (30 days) before randomization. An ICD
      (implantable cardioverter-defibrillator) is a small battery-powered electrical impulse
      generator which is implanted in patients who are at risk of sudden cardiac death due to
      ventricular fibrillation and ventricular tachycardia. The device is programmed to detect
      abnormal heart beats (cardiac arrhythmia) and correct it by delivering a jolt of electricity.

      The first group will undergo catheter-based sympathetic renal denervation. Renal Sympathetic
      Denervation is a procedure that uses a catheter probe inserted into the renal (kidney) artery
      that deactivates the nerves that are linked to high blood pressure.

      The second group (control group) will receive no further intervention after ICD implantation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 22, 2015</start_date>
  <completion_date type="Actual">January 9, 2019</completion_date>
  <primary_completion_date type="Actual">January 9, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to First Event Requiring ICD Therapy or Incessant VT</measure>
    <time_frame>24 months</time_frame>
    <description>The primary endpoint of this study is the time to first event requiring implantable cardioverter defibrillator (ICD) therapy or Incessant VT. (Ventricular tachycardia (VT) occurring below the ICD rate cut-off); this will be assessed in the on-treatment patient cohort. An event requiring ICD therapy is defined as an anti-tachycardia pacing (ATP) or shock therapy for ventricular tachycardia or fibrillation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Occurrences of Appropriate ICD Therapy</measure>
    <time_frame>24 months</time_frame>
    <description>Number of Occurrences of Appropriate ICD therapy assessed in the full intention-to-treat patient cohort. An Appropriate ICD therapy is defined as anti-tachycardia pacing (ATP) or shock therapy for ventricular tachycardia or fibrillation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Occurrences of Inappropriate ICD Therapy</measure>
    <time_frame>24 months</time_frame>
    <description>Number of occurrences of inappropriate shocks. Inappropriate ICD therapy are shocks given by the ICD for atrial fibrillation, supraventricular tachycardia or an abnormal sensing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Hospitalizations for Cardiovascular Causes</measure>
    <time_frame>24 months</time_frame>
    <description>Cumulative number of Hospitalizations for Cardiovascular Causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Episodes of Total VT Burden</measure>
    <time_frame>24 months</time_frame>
    <description>Cumulative Number of episodes of Total VT burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-Cause Mortality</measure>
    <time_frame>24 months</time_frame>
    <description>All-Cause Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Occurrence of ICD Storm</measure>
    <time_frame>24 months</time_frame>
    <description>The cumulative number of occurrences of ICD storm, defined as ≥3 appropriate shock therapies within 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BUN Measurements</measure>
    <time_frame>baseline, 6 months, 12 months, 24 months</time_frame>
    <description>Blood Urea Nitrogen (BUN) measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine Measurements</measure>
    <time_frame>baseline, 6 months, 12 months, 24 months</time_frame>
    <description>Creatinine measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure Related Adverse Events</measure>
    <time_frame>24 months</time_frame>
    <description>Procedure related adverse events including, but not limited to hematomas, pseudoaneurysms and renal artery stenosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Orthostatic Hypotension</measure>
    <time_frame>24 months</time_frame>
    <description>Number of participants who developed of orthostatic hypotension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Major Complication</measure>
    <time_frame>average 30 days</time_frame>
    <description>Number of Participants with Major Complication defined as death, stroke, myocardial infarction (MI) or any other serious adverse events related to the treatment or procedure within the first 30 days or through hospital discharge (whichever is longer)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>standard ICD implantation alone</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Boston Scientific Vessix Renal Denervation System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Ablation arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Boston Scientific Vessix Renal Denervation System</intervention_name>
    <description>Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
    <arm_group_label>Boston Scientific Vessix Renal Denervation System</arm_group_label>
    <other_name>Renal sympathetic denervation</other_name>
    <other_name>Renal denervation</other_name>
    <other_name>Denervation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥ 18 years of age

          -  Structural heart disease (post-MI, dilated cardiomyopathy, sarcoid myopathy,
             hypertrophic cardiomyopathy, etc.)

          -  Planned for ICD implantation for:

               -  i. Secondary prevention (eg: VT/VF arrest, sustained VT, syncope/inducible VT)

               -  ii. Primary prevention + inducible MMVT during induction via ICD lead testing

          -  Accessibility of renal vasculature (determined by renal angiography)

          -  Ability to understand the requirements of the study

          -  Willingness to adhere to study restrictions and comply with all post- procedural
             follow-up requirements

        Exclusion Criteria:

          -  Patient taking a Class I or III antiarrhythmic drug.

          -  Planned to undergo a cardiac VT ablation procedure

          -  NYHA Class IV Congestive Heart Failure

          -  MI within 30 days

          -  Known renovascular abnormalities that would preclude RSDN (eg, renal artery stenosis,
             previous renal artery stenting or angioplasty)

          -  Baseline orthostatic hypotension

          -  End stage renal failure on dialysis

          -  Life expectancy &lt;1 year for any medical condition

          -  Known pregnancy or positive β-HCG within 7 days of procedure.

          -  Coronary Artery Bypass Graft (CABG) within 30 days of the procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivek Reddy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Na Homolce Hospital</name>
      <address>
        <city>Prague</city>
        <zip>15030</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academician E.N. Meshalkin Novosibirsk State Budget Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Russian Federation</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 1, 2012</study_first_submitted>
  <study_first_submitted_qc>December 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2012</study_first_posted>
  <results_first_submitted>January 9, 2020</results_first_submitted>
  <results_first_submitted_qc>January 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 27, 2020</results_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Vivek Reddy</investigator_full_name>
    <investigator_title>Director Cardiac Arrhythmia Service, Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Renal sympathetic denervation</keyword>
  <keyword>Renal catheter ablation</keyword>
  <keyword>Ventricular tachycardia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 20, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/37/NCT01747837/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>First enrollment on Oct 22, 2015.
Last enrollment on May 3, 2017 with last study visit date conducted on Jan 9, 2019,
50 participants consented, 2 were found ineligible due to irregular renal anatomy during the angiography and not randomized.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Standard ICD Implantation Alone</title>
          <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
        </group>
        <group group_id="P2">
          <title>Boston Scientific Vessix Renal Denervation System</title>
          <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard ICD Implantation Alone</title>
          <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
        </group>
        <group group_id="B2">
          <title>Boston Scientific Vessix Renal Denervation System</title>
          <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="48"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" spread="10.76"/>
                    <measurement group_id="B2" value="63.3" spread="10.82"/>
                    <measurement group_id="B3" value="63.7" spread="10.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to First Event Requiring ICD Therapy or Incessant VT</title>
        <description>The primary endpoint of this study is the time to first event requiring implantable cardioverter defibrillator (ICD) therapy or Incessant VT. (Ventricular tachycardia (VT) occurring below the ICD rate cut-off); this will be assessed in the on-treatment patient cohort. An event requiring ICD therapy is defined as an anti-tachycardia pacing (ATP) or shock therapy for ventricular tachycardia or fibrillation.</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Event Requiring ICD Therapy or Incessant VT</title>
          <description>The primary endpoint of this study is the time to first event requiring implantable cardioverter defibrillator (ICD) therapy or Incessant VT. (Ventricular tachycardia (VT) occurring below the ICD rate cut-off); this will be assessed in the on-treatment patient cohort. An event requiring ICD therapy is defined as an anti-tachycardia pacing (ATP) or shock therapy for ventricular tachycardia or fibrillation.</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="177.2" spread="148.65"/>
                    <measurement group_id="O2" value="148.66" spread="148.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Occurrences of Appropriate ICD Therapy</title>
        <description>Number of Occurrences of Appropriate ICD therapy assessed in the full intention-to-treat patient cohort. An Appropriate ICD therapy is defined as anti-tachycardia pacing (ATP) or shock therapy for ventricular tachycardia or fibrillation.</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Occurrences of Appropriate ICD Therapy</title>
          <description>Number of Occurrences of Appropriate ICD therapy assessed in the full intention-to-treat patient cohort. An Appropriate ICD therapy is defined as anti-tachycardia pacing (ATP) or shock therapy for ventricular tachycardia or fibrillation.</description>
          <units>Occurences</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" spread="3.78"/>
                    <measurement group_id="O2" value="122" spread="20.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Occurrences of Inappropriate ICD Therapy</title>
        <description>Number of occurrences of inappropriate shocks. Inappropriate ICD therapy are shocks given by the ICD for atrial fibrillation, supraventricular tachycardia or an abnormal sensing.</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Occurrences of Inappropriate ICD Therapy</title>
          <description>Number of occurrences of inappropriate shocks. Inappropriate ICD therapy are shocks given by the ICD for atrial fibrillation, supraventricular tachycardia or an abnormal sensing.</description>
          <units>Occurrences</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="388" spread="70.4"/>
                    <measurement group_id="O2" value="86" spread="15.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Hospitalizations for Cardiovascular Causes</title>
        <description>Cumulative number of Hospitalizations for Cardiovascular Causes</description>
        <time_frame>24 months</time_frame>
        <population>cumulative number of hospitalizations</population>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Hospitalizations for Cardiovascular Causes</title>
          <description>Cumulative number of Hospitalizations for Cardiovascular Causes</description>
          <population>cumulative number of hospitalizations</population>
          <units>hospitalizations</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Episodes of Total VT Burden</title>
        <description>Cumulative Number of episodes of Total VT burden</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Episodes of Total VT Burden</title>
          <description>Cumulative Number of episodes of Total VT burden</description>
          <units>Episodes</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="513"/>
                    <measurement group_id="O2" value="671"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All-Cause Mortality</title>
        <description>All-Cause Mortality</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>All-Cause Mortality</title>
          <description>All-Cause Mortality</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Occurrence of ICD Storm</title>
        <description>The cumulative number of occurrences of ICD storm, defined as ≥3 appropriate shock therapies within 24 hours</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Occurrence of ICD Storm</title>
          <description>The cumulative number of occurrences of ICD storm, defined as ≥3 appropriate shock therapies within 24 hours</description>
          <units>occurences</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>BUN Measurements</title>
        <description>Blood Urea Nitrogen (BUN) measurements</description>
        <time_frame>baseline, 6 months, 12 months, 24 months</time_frame>
        <population>data only available for those participants who returned for respective study visits</population>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>BUN Measurements</title>
          <description>Blood Urea Nitrogen (BUN) measurements</description>
          <population>data only available for those participants who returned for respective study visits</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.31" spread="6.24"/>
                    <measurement group_id="O2" value="10.6" spread="4.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" spread="5.77"/>
                    <measurement group_id="O2" value="11.71" spread="7.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.02" spread="5.76"/>
                    <measurement group_id="O2" value="8.71" spread="6.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.09" spread="3.75"/>
                    <measurement group_id="O2" value="8" spread="3.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatinine Measurements</title>
        <description>Creatinine measurements</description>
        <time_frame>baseline, 6 months, 12 months, 24 months</time_frame>
        <population>data only available for those participants who returned for respective study visits</population>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Creatinine Measurements</title>
          <description>Creatinine measurements</description>
          <population>data only available for those participants who returned for respective study visits</population>
          <units>µmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="23"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105" spread="32.57"/>
                    <measurement group_id="O2" value="102" spread="20.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108" spread="24.6"/>
                    <measurement group_id="O2" value="108" spread="43.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110" spread="35.28"/>
                    <measurement group_id="O2" value="104" spread="28.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107" spread="24.97"/>
                    <measurement group_id="O2" value="98" spread="14.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedure Related Adverse Events</title>
        <description>Procedure related adverse events including, but not limited to hematomas, pseudoaneurysms and renal artery stenosis.</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Procedure Related Adverse Events</title>
          <description>Procedure related adverse events including, but not limited to hematomas, pseudoaneurysms and renal artery stenosis.</description>
          <units>Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Orthostatic Hypotension</title>
        <description>Number of participants who developed of orthostatic hypotension</description>
        <time_frame>24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Orthostatic Hypotension</title>
          <description>Number of participants who developed of orthostatic hypotension</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Major Complication</title>
        <description>Number of Participants with Major Complication defined as death, stroke, myocardial infarction (MI) or any other serious adverse events related to the treatment or procedure within the first 30 days or through hospital discharge (whichever is longer)</description>
        <time_frame>average 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard ICD Implantation Alone</title>
            <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
          </group>
          <group group_id="O2">
            <title>Boston Scientific Vessix Renal Denervation System</title>
            <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Major Complication</title>
          <description>Number of Participants with Major Complication defined as death, stroke, myocardial infarction (MI) or any other serious adverse events related to the treatment or procedure within the first 30 days or through hospital discharge (whichever is longer)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard ICD Implantation Alone</title>
          <description>These subjects will undergo standard ICD implantation alone (if not already present)</description>
        </group>
        <group group_id="E2">
          <title>Boston Scientific Vessix Renal Denervation System</title>
          <description>These subjects will undergo standard ICD implantation (if not already present) plus renal sympathetic denervation.
Boston Scientific Vessix Renal Denervation System: Renal sympathetic denervation is modulation of the nerves which run along the renal arteries (the renal sympathetic nerves) with radiofrequency energy. This is the same energy source used to perform your heart ablation.
Boston Scientific Vessix Renal Denervation System, Boston Scientific, Inc., Quincy, Massachusetts</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrhythmias</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Episode of Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Heart Failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Stable exertional angina</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Collapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Ischemic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bedsore of pocket ICD</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Skin erosion on the place of ICD</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Hip Surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Emphysema Thoracalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pocket Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Implantation of BIV IC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Pocket Revision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Puncture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Cardiac Arrhythmias</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Collapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Neoplasm of Left Kidney</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Respiratory Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Groin Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Dislocation of the Atrial Electrode</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sam Commack</name_or_title>
      <organization>Icahn School of Medicine at Mount Sinai</organization>
      <phone>212-824-8931</phone>
      <email>sam.cammack@mountsinai.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

